Blood test trial seeks to predict ovarian Cancer's next move
NCT ID NCT04511988
Summary
This study is testing whether a simple blood test, called a liquid biopsy, can be used to understand how ovarian cancer changes over time and predict if it will come back or progress. It involves 20 newly diagnosed patients who will give blood samples during their standard treatment for two years. The goal is to gather knowledge, not to test a new therapy for the cancer itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54506, France
Conditions
Explore the condition pages connected to this study.